NIH R01 · 2025
The underutilization of Pre-Exposure Prophylaxis (PrEP)1–5 in the US stems from a perfect storm of social, health, political, and economic factors contributing to low uptake and retention.6–14 A variety of pharmacist-led PrEP models have demonstrated feasibility and success.15–22 However, most states limit the pharmacists’ scope of practice.23 This project will prove a theory-based, multi-level, longitudinal analysis of expanding the scope of practice of pharmacists implemented to promote PrEP uptake with attention to their longer-term impacts on retention to care and their economic impact. This complex dynamic will be examined through a multi-source, national analysis of datasets. The…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.